Lotus Pharmaceutical has announced a share buyback program, demonstrating confidence in its strong fundamentals and long-term growth potential. The company plans to repurchase up to 4 million shares on the open market between April 11 and June 9, with a buyback price range of NT$180 to NT$245 per share, representing approximately 1.51% of its total outstanding shares.
Read more
